Home

Jean George

CIK 1291804 · last filed 2024-02-16

Jean George is a corporate insider who has filed 43 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider exercised options covering $23.9K of CYT on Feb 16, 2024. Across all open-market trades the lifetime net is −$34.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $615.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$615.4K

Companies

8

Total Filings

43

Lifetime Open-Market Net

-$34.38M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cyteir Therapeutics, Inc. (CYT) Delisted Director 2,458,415 $3.02 $7.42M $0 4 2024-02-16
Calithera Biosciences, Inc. (CALA) Delisted Director 90,504 $0.00 $27 $3.00M 8 2021-06-14
ALXO 10%+ Owner 309,222 $1.99 $615.4K $68.40M 1 2020-07-22
ACCELERON PHARMA INC (XLRN) Delisted Director 5,127 $178.75 $916.5K -$57.46M 15 2020-01-24
Astria Therapeutics, Inc. (CATB) Delisted Director 90,764 $8.54 $775.1K $3.11M 4 2018-06-07
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 5,786 — — -$51.43M 9 2015-07-23
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 27,939 — — $0 1 2013-05-30
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Director — $1.95 — $0 1 2007-05-03

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-16 Cyteir Therapeutics, Inc. (CYT) Delisted Exer (M) +14,150 $23.9K EDGAR
2023-02-07 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2022-02-24 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2021-06-24 Cyteir Therapeutics, Inc. (CYT) Delisted Conv (C) +2,444,268 $0 EDGAR
2021-06-14 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
2020-07-22 ALXO Mixed +36,820,539 $68.40M EDGAR
2020-06-11 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
2020-01-24 ACCELERON PHARMA INC (XLRN) Delisted Grant (A) +1,377 $0 EDGAR
2019-06-28 ACCELERON PHARMA INC (XLRN) Delisted Mixed — -$504.1K EDGAR
2019-06-03 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.